SS

Sunil Sheari

Active Director Director DIN 07112409
DIN 07112409 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Sunil Sheari

Data last updated:

Sunil Sheari is a Director at Novell Pharma Private Limited (since 2015). The company operates in Pharma. Novell Pharma Private Limited reported revenue of ₹75.4 Lakh (FY 2024).

DIN 07112409
Primary Designation Director
Industry Pharma
First Appointment 13 Mar 2015
Oldest Company Age 11 yrs
Largest company Novell Pharma Private Limited · ₹75.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Novell Pharma Private Limited U24230TG2015PTC098025
Director13 Mar 20152015₹75.4 Lakh (FY 2024)Active

Board colleagues of Sunil Sheari

NameDINCompanyDesignation
Prithi Gajula10147007Novell Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novell Pharma Private Limited
Premium access

Shareholding and investment profile for Sunil Sheari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Sheari

Sunil Sheari currently holds 1 directorship: Novell Pharma Private Limited (Director, since 13 Mar 2015, revenue ₹75.4 Lakh (FY 2024)).

Sunil Sheari was first appointed on 13 Mar 2015 as Director at Novell Pharma Private Limited.

The current boards of Sunil Sheari's companies include Prithi Gajula (Novell Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available